Dorman Products vs Valvoline
DORM and VVV side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DORM and VVV compare
Dorman Products and Valvoline are about the same size, with market caps of $4.0B and $4.1B.
On earnings, Dorman Products is cheaper: it trades at 18.8× trailing earnings, against 40.9× for Valvoline.
Valvoline grew revenue faster over the last twelve months (16.1% versus 3.3% for Dorman Products).
Dorman Products keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with 5.2% at Valvoline.
Dorman Products scores higher on the StockData Score (14 against 9 for Valvoline), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DORM | VVV |
|---|---|---|
| Size and price | ||
| Market cap | $4.0B | $4.1B |
| Share price | $136.01 | $32.29 |
| Change, 1 year | 1.9% | −1.3% |
| Change, 5 years | 19.1% | −5.8% |
| Beta (5Y) | 0.71 | 0.81 |
| Employees | 300 | 11K |
| StockData Score | ||
| Total score | 14 (better) | 9 |
| Valuation score | 2 (better) | 1 |
| Growth score | 2 | 3 (better) |
| Performance score | 5 (better) | 4 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 18.8× (better) | 40.9× |
| P/S | 1.9× (better) | 2.1× |
| P/B | 2.7× (better) | 9.9× |
| EV/EBITDA | 11.8× (better) | 18.7× |
| P/FCF | 18.8× (better) | 30.4× |
| PEG | 0.95 | – |
| FCF yield | 5.3% (better) | 3.3% |
| Fair value | $116.92 | $19.95 |
| Margin of safety | −16.3% (better) | −61.9% |
| Growth | ||
| Revenue growth (TTM) | 3.3% | 16.1% (better) |
| Revenue growth, 5Y average | 14.3% | 18.7% (better) |
| Net income growth (TTM) | −3.0% (better) | −63.5% |
| EPS growth (TTM) | −1.8% (better) | −63.3% |
| EPS growth, 5Y average | 15.0% (better) | −0.60% |
| Profitability | ||
| Gross margin | 42.3% (better) | 38.3% |
| Operating margin | 14.5% | 15.3% (better) |
| Net margin | 10.2% (better) | 5.2% |
| FCF margin | 9.9% (better) | 6.9% |
| Return on equity | 15.0% | 27.8% (better) |
| Return on invested capital | 12.7% (better) | 10.9% |
| Financial health | ||
| Debt / equity | 0.29 (better) | 3.84 |
| Net debt / EBITDA | 0.84 (better) | 5.04 |
| Interest coverage | 11.9× | – |
| Current ratio | 3.60 (better) | 0.70 |
| Altman Z-score | 5.04 (better) | 1.75 |
| Piotroski F-score | 8 | 8 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 97.0% | 117% |
| Held by insiders | 8.2% | 0.33% |
| Insider net buying, 12 months | −$1.7M | $308K (better) |
| Short interest, % of float | 5.8% | 12.1% |
Go deeper
- DORM stock overview
- DORM income statement
- DORM valuation and score
- VVV stock overview
- VVV income statement
- VVV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.